Skip to content

Clinical trials

Phase 2 Leukemia, Myeloid, Acute trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Phase 2 Country / region: Australia Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20081
20091
20102
20132
20141
20183
20191
20201
20211
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated3
Active, not recruiting2
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
ASLAN Pharmaceuticals1
Antisoma Research1
Bayside Health1
Cephalon1
Cogent Biosciences, Inc.1
Daiichi Sankyo1
GCP-Service International West GmbH1
GlaxoSmithKline1
Kirby Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute18
Leukemia6
Myelodysplastic Syndromes4
Leukemia, Myelomonocytic, Chronic2
Neoplasms2
Recurrence2
Bacterial Infections1
Congenital Abnormalities1
Hematologic Diseases1
Hematologic Neoplasms1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.